FDA Warning and Removal of Rosiglitazone From VA National Formulary
After the FDA warning and removal of rosiglitazone from the VA National Formulary, glucose control may have declined among those discontinuing rosiglitazone without receiving replacement medication.
Cost-Effectiveness of Medicare Drug Plans in Schizophrenia and Bipolar Disorder
In Medicare Part D, generic drug coverage was cost saving compared with no coverage in bipolar disorder and schizophrenia while improving health outcomes.
Optimal Approach to Improving Trauma Triage Decisions: A Cost-Effectiveness Analysis
To set priorities for quality improvement in trauma triage, we compared the cost-effectiveness of current practice with interventions to improve physician adherence to clinical guidelines.
Economic Model for Emergency Use Authorization of Intravenous Peramivir
The US Food and Drug Administration granted emergency use authorization of intravenous neuraminidase inhibitors for patients with 2009 influenza A (H1N1), creating a need for economic studies.
Screening Cardiac Surgery Patients for MRSA: An Economic Computer Model
Routine preoperative MRSA screening of cardiac surgery patients could provide substantial economic value to third-party payers and hospitals under a wide range of circumstances.
Cost-Effectiveness of Pneumococcal Polysaccharide Vaccine Among Healthcare Workers During an Influenza Pandemic
Pneumococcal polysaccharide vaccination of healthcare workers during an influenza pandemic is cost-effective from a societal perspective but not from a hospital perspective without external subsidy.
Economics of Influenza Vaccine Administration Timing for Children
Vaccinating children earlier (ie, September or October) can provide net economic benefit to society and to third-party payers. Vaccination of children remained cost-effective through December.
2 Clarke Drive Cranbury, NJ 08512